Association between tumor necrosis factor alpha-238G/a polymorphism and tuberculosis susceptibility: A meta-analysis study

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Zhang, Zhijiao ^a   Zhu, Hang ^a   Pu, Xudi ^a   Meng, Siying ^a   Zhang, Fan ^a   Xun, Lei ^a   Liu, Qin ^a   Wang, Yang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Meta analysis; Polymorphism; Susceptibility; TNF ; Tuberculosis

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CALCULATION; CASE CONTROL STUDY; CHI SQUARE TEST; CONFIDENCE INTERVAL; ETHNICITY; GENETIC ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION SENSITIVITY; SINGLE NUCLEOTIDE POLYMORPHISM; TUBERCULOSIS; TUMOR NECROSIS FACTOR ALPHA GENE;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84870062244     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-328     Document Type: Article

References (39)

1. World Health Organization The burden of disease caused by TB Global tuberculosis control 2011, 9-27. World Health Organization.
2. World Health Organization Tuberculosis World Health Organization., http://www.who.int/mediacentre/factsheets/fs104/en/index.html
3. Schurr E. Is susceptibility to tuberculosis acquired or inherited?. J Intern Med 2007, 261:106-111.
4. Lewis SJ, Baker I, Davey Smith G. Meta-analysis of vitamin D receptor polymorphisms and pulmonary tuberculosis risk. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease 2005, 9:1174-1177.
5. Denholm JT, McBryde ES, Eisen DP. Mannose-binding lectin and susceptibility to tuberculosis: a meta-analysis. Clin Exp Immunol 2010, 162:84-90. 10.1111/j.1365-2249.2010.04221.x, 2990933, 20636396.
6. Can T, Yonglang Z, Jie Z, et al. The +874T/A polymorphism in the interferon-gamma gene and tuberculosis risk: An update by meta-analysis. Hum Immunol 2011, 72:1137-1142. 10.1016/j.humimm.2011.07.310, 21864611.
7. Moeller M, Hoal EG. Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis. Tuberculosis (Amsterdam) 2010, 90:71-83.
8. Engele M, Stoessel E, Castiglione K, et al. Induction of TNF in human alveolar macrophages as a potential evasion mechanism of virulent Mycobacterium tuberculosis. J Immunol 2002, 168:1328-1337.
9. Mohan VP, Scanga CA, Yu K, et al. Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: Possible role for limiting pathology. Infect Immun 2001, 69:1847-1855. 10.1128/IAI.69.3.1847-1855.2001, 98092, 11179363.
10. Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001, 345:1098-1104. 10.1056/NEJMoa011110, 11596589.
11. Messer G, Spengler U, Jung MC, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 1991, 173:209-219. 10.1084/jem.173.1.209, 2118757, 1670638.
12. Aguillon JC, Cruzat A, Aravena O, et al. Could single-nucleotide polymorphisms (SNPs) affecting the tumour necrosis factor promoter be considered as part of rheumatoid arthritis evolution?. Immunobiology 2006, 211:75-84. 10.1016/j.imbio.2005.09.005, 16446172.
13. Merza M, Farnia P, Anoosheh S, et al. The NRAMPI, VDR and TNF-alpha Gene Polymorphisms in Iranian Tuberculosis Patients: The Study on Host Susceptibility. Braz J Infect Dis 2009, 13:252-256.
14. Sharma S, Rathored J, Ghosh B, et al. Genetic polymorphisms in TNF genes and tuberculosis in North Indians. BMC Infect Dis 2010, 10:165. 10.1186/1471-2334-10-165, 2894837, 20537163.
15. Bayley JP, Ottenhoff THM, Verweij CL. Is there a future for TNF promoter polymorphisms?. Genes Immun 2004, 5:315-329. 10.1038/sj.gene.6364055, 14973548.
16. Correa PA, Gomez LM, Cadena J, et al. Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol 2005, 32:219-224.
17. Amirzargar AA, Rezaei N, Jabbari H, et al. Cytokine single nucleotide polymorphisms in Iranian patients with pulmonary tuberculosis. Eur Cytokine Netw 2006, 17:84-89.
18. Selvaraj P, Sriram U, Mathan Kurian S, et al. Tumour necrosis factor alpha (-238 and -308) and beta gene polymorphisms in pulmonary tuberculosis: haplotype analysis with HLA-A, B and DR genes. Tuberculosis 2001, 81:335-341. 10.1054/tube.2001.0307, 11800584.
19. Fitness J, Floyd S, David K, et al. Large-scale candidate gene study of tuberculosis susceptiblity in the karonga district of northern malawi. AmJTrop Med Hyg 2004, 71:341-349.
20. Vejbaesya S, Chierakul N, Luangtrakool P, et al. NRAMP1 and TNF-alpha polymorphisms and susceptibility to tuberculosis in Thais. Respirology 2007, 12:202-206. 10.1111/j.1440-1843.2006.01037.x, 17298451.
21. Ates T, Musellim B, Ongen G, et al. Interleukin-10 and Tumor Necrosis Factor-α Gene Polymorphisms in Tuberculosis. J Clin Immunol 2008, 28:232-236. 10.1007/s10875-007-9155-2, 18071881.
22. G Cochran W. The combination of estimates from different experiments. Biometrics 1954, 10:101-129.
23. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558. 10.1002/sim.1186, 12111919.
24. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22:719-748.
25. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188. 10.1016/0197-2456(86)90046-2, 3802833.
26. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101. 10.2307/2533446, 7786990.
27. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed) 1997, 315:629-634.
28. M R, F R. GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism. J Heredity 1995, 86:248-249.
29. Rousset F. Genepop'007: a complete reimplementation of the Genepop software for Windows and Linux. Mol Ecol Resources 2008, 8:103-106.
30. Chunmei J, Anya C, Jun L, et al. Relationship of tumor necrosis factor alpha and beta genetic polymorphisms with onset of pulmonary tuberculosis in Hans of north China: A 1:1 paired case-control study. Chinses Journal of Clinical Rehabilitation 2006, 10:4.
31. Fan H, Wang Z, Feng F, et al. Association of TNF-α-238G/A and 308 G/A Gene Polymorphisms with Pulmonary Tuberculosis among Patients with Coal Worker's Pneumoconiosis. Biomed Environ Sci 2010, 23:137-145. 10.1016/S0895-3988(10)60043-8, 20514989.
32. Zhaohai L. Association between Cytokine gene polymorphisms and pulmonary tuberculosis 2009, Nanchang University, immunology, PhD thesis.
33. Trajkov D, Trajchevska M, Arsov T, et al. Association of 22 cytokine gene polymorphisms with tuberculosis in Macedonians. Indian J Tuberc 2009, 56:117-131.
34. Anoosheh S, Farnia P, Kargar M. Association between TNF-Alpha (-857) Gene Polymorphism and Susceptibility to Tuberculosis. Iranian Red Crescent Medical Journal 2010, 13:243-248.
35. Chunyan L, Yufang Y, Jufei F, et al. Association between Bone-joint tuberculosis and TNF-α polymorphism. Chinese Journal of Spine and Spinal Cord 2011, 21:427-429.
36. Khoury MJ, Yang Q. The future of genetic studies of complex human diseases: an epidemiologic perspective. Epidemiology (Cambridge, Mass) 1998, 9:350-354.
37. Tsantes AE, Nikolopoulos GK, Bagos PG, et al. Lack of association between the platelet glycoprotein Ia C807T gene polymorphism and coronary artery disease: A meta-analysis. Int J Cardiol 2007, 118:189-196. 10.1016/j.ijcard.2006.06.047, 17023078.
38. Qin W, Ping Z, Lixin Q, et al. TNF-308 gene polymorphism and tuberculosis susceptibility: a meta-analysis involving 18 studies. Mol Biol Rep 2012, 39:3393-3400. 10.1007/s11033-011-1110-x, 21735105.
39. Gerard C, Bruyns C, Marchant A, et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993, 177:547-550. 10.1084/jem.177.2.547, 2190913, 8426124.